| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B Bass, B Weinshenker, G P Rice, J H Noseworthy, M G Cameron, W Hader, S Bouchard, G C Eber. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 15. issue 1. 1988-04-21. PMID:3345456. |
both baclofen and tizanidine appear to be useful adjuncts in the treatment of spasticity in patients with multiple sclerosis. |
1988-04-21 |
2023-08-11 |
Not clear |
| Y Lapierre, S Bouchard, C Tansey, D Gendron, W J Barkas, G S Franci. Treatment of spasticity with tizanidine in multiple sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 14. issue 3 Suppl. 1988-01-13. PMID:3676923. |
treatment of spasticity with tizanidine in multiple sclerosis. |
1988-01-13 |
2023-08-11 |
Not clear |
| b' R Stien, H J Nordal, S I Oftedal, M Sletteb\\xc3\\xb. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen. Acta neurologica Scandinavica. vol 75. issue 3. 1987-06-09. PMID:3554879.' |
the treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen. |
1987-06-09 |
2023-08-11 |
Not clear |
| b' R Stien, H J Nordal, S I Oftedal, M Sletteb\\xc3\\xb. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen. Acta neurologica Scandinavica. vol 75. issue 3. 1987-06-09. PMID:3554879.' |
the anti-spastic effect of a new drug, tizanidine, was compared with that of baclofen in a double-blind clinical trial; 40 seriously handicapped patients with multiple sclerosis (ms) were randomly allocated treatment with one or the other drug for a 6-week period. |
1987-06-09 |
2023-08-11 |
Not clear |
| V Heazlewood, P Symoniw, P Maruff, M J Eadi. Tizanidine--initial pharmacokinetic studies in patients with spasticity. European journal of clinical pharmacology. vol 25. issue 1. 1983-11-23. PMID:6617726. |
the time-course of plasma concentrations of the antispasticity agent tizanidine were measured by a specific radioimmune-assay in six adults who had severe spasticity due to multiple sclerosis. |
1983-11-23 |
2023-08-12 |
human |
| C Smolenski, S Muff, S Smolenski-Kaut. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. Current medical research and opinion. vol 7. issue 6. 1981-08-20. PMID:7016449. |
a double-blind comparative trial of new muscle relaxant, tizanidine (ds 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. |
1981-08-20 |
2023-08-12 |
Not clear |
| C Smolenski, S Muff, S Smolenski-Kaut. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. Current medical research and opinion. vol 7. issue 6. 1981-08-20. PMID:7016449. |
a double-blind trial with two parallel groups was carried out to compare the antispastic effect and tolerability of a new muscle relaxant, tizanidine (ds 103-282), with those of baclofen in the treatment of spasticity due to multiple sclerosis. |
1981-08-20 |
2023-08-12 |
Not clear |